X0306 4 2018-02-07 0 0001488613 Foundation Medicine, Inc. FMI 0001696923 Cox Troy C/O FOUNDATION MEDICINE, INC. 150 SECOND STREET CAMBRIDGE MA 02141 1 1 0 0 Chief Executive Officer Common Stock 2018-02-07 4 S 0 26713 70.13 D 224345 D Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on February 6, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.12 to $70.46, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. Robert W. Hesslein, Attorney-in-Fact for Troy Cox 2018-02-09